Reproductive findings in male animals exposed to selective survival of motor neuron 2 (SMN2) gene splicing-modifying agents-Reference-Cited by-同舟云学术

Reproductive findings in male animals exposed to selective survival of motor neuron 2 (SMN2) gene splicing-modifying agents

Published:2023-06 Issue: Volume:118 Page:108360
ISSN:0890-6238
Container-title:Reproductive Toxicology
language:en
Short-container-title:Reproductive Toxicology

Author:

Mueller Lutz,Barrow Paul,Jacobsen Björn,Ebeling Martin,Weinbauer Gerhard

Funder

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Toxicology

Reference26 articles.

1. Preface;Sumner,2017

2. Oral SMN2 splicing modifiers in spinal muscular atrophy: Proof-of-mechanism and ongoing clinical studies;Marquet;Eur. J. Paediatric Neurol.: EJPN: Off. J. Eur. Paediatric Neurol. Soc.,2017

3. The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: results from trials in healthy adults and patients with spinal muscular atrophy;Kletzl;Neuromuscul. Disord.,2019

4. Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA);Ratni;J. Med. Chem.,2018

5. Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls;Darras;N. Engl. J. Med.,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental variations of the reproductive organs of ganders from different goose breeds and the underlying mechanisms;Poultry Science;2024-11

2. Clinical perspectives: Treating spinal muscular atrophy;Molecular Therapy;2024-08

3. Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians;Drugs;2024-06-15

4. Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing Modifiers;Neurology and Therapy;2024-05-16

5. Exploration of adverse events associated with risdiplam use: Retrospective cases from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database;PLOS ONE;2024-03-01